• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Reckitt Benckiser to buy India's Paras Pharma

      Posted Atmoneycontrol.com

      British consumer goods company Reckitt Benckiser said on Sunday it agreed to buy privately held Indian firm Paras Pharmaceuticals for Rs 3260 crore (USD 726 mn).

      Paras, which is expected to clock sales of more than Rs 10 crore in 2010, makes several over the counter medications, including Moov pain relief ointment, Krack heel care lotion, and D'Cold cold remedy.

      Private equity firm Actis, which owns 63% of Paras, and the firm's other shareholders have agreed to sell theior stakes in the company. Paras' other shareholders include Sequoia Capital, Paras founder Girish Patel and his family.

      In October, India's Business Standard newspaper reported that GlaxoSmithKline Plc, Sanofi-Aventis, Novartis AG and US based Johnson & Johnson had submitted concrete bids to acquire majority stake in Paras.

      It reported that Japan's Taisho Pharmaceutical had also been expected to join the race.

      Reckitt Benckiser was advised by JP Morgan on the deal. Actis and the other Paras shareholders were advised by Morgan Stanley.

      Dec 14, 2010


      Share this Article!

    Back to top^